IVVD Q3 2021 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena

IVVDInvivyd, Inc.

$252M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$60M

Net Income

-$60M

EPS (Diluted)

$-0.98

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$54M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$686M

Total Liabilities

$53M

Stockholders' Equity

$633M

Cash & Equivalents

$478M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$60M	-$48M	-25.8%
Net Income	-$60M	-$48M	-25.8%